Literature DB >> 35373045

Equity Is Key to Build Back Better after COVID-19: Prioritize Noncommunicable Diseases and Kidney Health.

Valerie Ann Luyckx1.   

Abstract

Entities:  

Keywords:  COVID-19; build back better; chronic kidney disease; equity; global health; health systems; kidney health; multisectoral action; non-communicable diseases; public health; sustainable development goals

Mesh：

Year:  2021        PMID： 35373045      PMCID： PMC8791323          DOI： 10.34067/KID.0006932020

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  12 in total

1.  Why have Non-communicable Diseases been Left Behind?

Authors:  Florencia Luna; Valerie A Luyckx
Journal:  Asian Bioeth Rev       Date:  2020-03-20

2.  Time to deliver: report of the WHO Independent High-Level Commission on NCDs.

Authors:  Sania Nishtar; Sauli Niinistö; Maithripala Sirisena; Tabaré Vázquez; Veronika Skvortsova; Adolfo Rubinstein; Festus Gontebanye Mogae; Pirkko Mattila; Seyyed Hassan Ghazizadeh Hashemi; Sicily Kariuki; José Narro Robles; Isaac F Adewole; Adboulaye Diouf Sarr; Kim Yong Gan; Saia Ma'u Piukala; Abdul Rahman Bin Mohammed Al Owais; Eric Hargan; George Alleyne; Ala Alwan; Arnaud Bernaert; Michael Bloomberg; Katie Dain; Tom Frieden; Vikram Harshad Patel; Annette Kennedy; Ilona Kickbusch
Journal:  Lancet       Date:  2018-06-01       Impact factor: 79.321

3.  Chronic disease as risk multiplier for disadvantage.

Authors:  Francisca Stutzin Donoso
Journal:  J Med Ethics       Date:  2018-03-06       Impact factor: 2.903

Review 4.  Syndemic vulnerability and the right to health.

Authors:  Sarah S Willen; Michael Knipper; César E Abadía-Barrero; Nadav Davidovitch
Journal:  Lancet       Date:  2017-03-04       Impact factor: 79.321

Review 5.  The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion.

Authors:  Gene Bukhman; Ana O Mocumbi; Rifat Atun; Anne E Becker; Zulfiqar Bhutta; Agnes Binagwaho; Chelsea Clinton; Matthew M Coates; Katie Dain; Majid Ezzati; Gary Gottlieb; Indrani Gupta; Neil Gupta; Adnan A Hyder; Yogesh Jain; Margaret E Kruk; Julie Makani; Andrew Marx; J Jaime Miranda; Ole F Norheim; Rachel Nugent; Nobhojit Roy; Cristina Stefan; Lee Wallis; Bongani Mayosi
Journal:  Lancet       Date:  2020-09-14       Impact factor: 79.321

6.  Financing national non-communicable disease responses.

Authors:  Luke Nelson Allen
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

7.  Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries.

Authors:  Margaret E Kruk; Anna D Gage; Naima T Joseph; Goodarz Danaei; Sebastián García-Saisó; Joshua A Salomon
Journal:  Lancet       Date:  2018-09-05       Impact factor: 79.321

8.  Comparison of the Complexity of Patients Seen by Different Medical Subspecialists in a Universal Health Care System.

Authors:  Marcello Tonelli; Natasha Wiebe; Braden J Manns; Scott W Klarenbach; Matthew T James; Pietro Ravani; Neesh Pannu; Jonathan Himmelfarb; Brenda R Hemmelgarn
Journal:  JAMA Netw Open       Date:  2018-11-02

9.  Ethnic and racial disparities in COVID-19-related deaths: counting the trees, hiding the forest.

Authors:  Sanni Yaya; Helena Yeboah; Carlo Handy Charles; Akaninyene Otu; Ronald Labonte
Journal:  BMJ Glob Health       Date:  2020-06

10.  Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2020-02-13       Impact factor: 79.321
View more
  1 in total

Review 1.  Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions.

Authors:  Duvuru Geetha; Andreas Kronbichler; Megan Rutter; Divya Bajpai; Steven Menez; Annemarie Weissenbacher; Shuchi Anand; Eugene Lin; Nicholas Carlson; Stephen Sozio; Kevin Fowler; Ray Bignall; Kathryn Ducharlet; Elliot K Tannor; Eranga Wijewickrama; Muhammad I A Hafidz; Vladimir Tesar; Robert Hoover; Deidra Crews; Charles Varnell; Lara Danziger-Isakov; Vivekanand Jha; Sumit Mohan; Chirag Parikh; Valerie Luyckx
Journal:  Nat Rev Nephrol       Date:  2022-08-24       Impact factor: 42.439
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.